MARKET

FHTX

FHTX

Foghorn Therapeutics Inc.
NASDAQ
5.55
+0.29
+5.51%
After Hours: 5.55 0 0.00% 16:10 02/13 EST
OPEN
5.29
PREV CLOSE
5.26
HIGH
5.74
LOW
5.29
VOLUME
121.02K
TURNOVER
--
52 WEEK HIGH
6.95
52 WEEK LOW
2.945
MARKET CAP
325.08M
P/E (TTM)
-4.8421
1D
5D
1M
3M
1Y
5Y
1D
The top-performing pharma and biotech stocks as group sees resurgence
Seeking Alpha · 18h ago
Weekly Report: what happened at FHTX last week (0202-0206)?
Weekly Report · 5d ago
Foghorn Therapeutics to Present at Guggenheim Emerging Outlook Biotech Summit
Reuters · 02/03 12:00
Weekly Report: what happened at FHTX last week (0126-0130)?
Weekly Report · 02/02 09:41
Weekly Report: what happened at FHTX last week (0119-0123)?
Weekly Report · 01/26 09:42
Weekly Report: what happened at FHTX last week (0112-0116)?
Weekly Report · 01/19 09:45
FOGHORN THERAPEUTICS ANNOUNCES CLOSING OF $50 MILLION REGISTERED DIRECT FINANCING AT A 30% PREMIUM
Reuters · 01/13 21:05
Press Release: Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
Dow Jones · 01/13 21:05
More
About FHTX
Foghorn Therapeutics Inc. is a clinical-stage, precision therapeutics biotechnology company. The Company is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control platform, it is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is also developing multiple product candidates in oncology. The Gene Traffic Control platform provides an integrated and mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within this system. Its platform enables to produce components of the chromatin regulatory system at scale, thereby allowing to identify these genetic dependencies, understand their mechanism and target their vulnerabilities.

Webull offers Foghorn Therapeutics Inc stock information, including NASDAQ: FHTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FHTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FHTX stock methods without spending real money on the virtual paper trading platform.